GENE ONLINE|News &
Z Squared Inc. Approved for Nasdaq Listing with Coeptis Therapeutics as Equity Holder
Coeptis Therapeutics Holdings, Inc. announced the approval of Z Squared Inc.’s application to list its common stock on the Nasdaq Stock Market. The announcement marks a significant development for Z Squared Inc., a company in which Coeptis holds an equity interest.
According to the statement, the Nasdaq listing will allow Z Squared Inc. to trade its shares publicly under a designated ticker symbol, though specific details regarding the timing of the listing or trading commencement were not disclosed. Coeptis Therapeutics, which focuses on developing innovative medical technologies and therapies, highlighted this milestone as part of its broader investment strategy in emerging companies within the healthcare sector. Further updates regarding Z Squared’s Nasdaq debut are expected to follow as additional information becomes available.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 7, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Study Identifies Unique Risk Factors and Injury Patterns in Preterm Infants with PAIS and CSVT
2026-04-17
Study Finds Gaps in Measles Vaccination Coverage and Awareness Among U.S. Emergency Room Patients
2026-04-17
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
